Guangzhou Baiy | 600332 - Current Liabilities


Guangzhou Baiy reported CNY37.76B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Aspen Pharmacare ZAR 16.23B 455M Jun/2026
Cipla INR 69.77B 366.6M Sep/2026
Dr.Reddys Laboratories INR 154.3B 3.04B Sep/2026
Jiangsu Hengrui CNY 6.9B 2.65B Sep/2026
Kalbe Farma IDR 5.6T 925.49B Mar/2026
Richter Gedeon HUF 179.31B 8.13B Mar/2026
Sh Fosun Pharma CNY 35.3B 3.29B Sep/2026
Sh Pharmaceutical CNY 140.51B 88.41M Sep/2026
Sun Pharmaceuticals INR 226.22B 7.93B Mar/2026
Teva Pharmaceutical Industries USD 15.65B 2.11B Jun/2026